Exane Derivatives’s Horizon Bancorp HBNC Stock Holding History
Bought
Maintained
Sold
Other funds holding HBNC
PCA
Exane Derivatives's HBNC Position: Q2 2022 in Review
Exane Derivatives reduced its Horizon Bancorp (HBNC) stake by 82% in Q2 2022, selling an estimated $16.4K and leaving 207 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #403.
Exane Derivatives first reported a position in HBNC in Q1 2022 and has held it in 2 quarters since. The position peaked at $21K in Q1 2022. 155 funds tracked by Wall St. Rank hold HBNC as of Q2 2022.
- Exane Derivatives held 207 shares of Horizon Bancorp worth $3.6K as of Q2 2022.
- Exane Derivatives sold 919 Horizon Bancorp shares in Q2 2022, an estimated $16.4K.
- Horizon Bancorp made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #403 holding.
- Exane Derivatives first reported a position in Horizon Bancorp in Q1 2022 and has held it in 2 quarters since.
- Exane Derivatives's Horizon Bancorp position peaked at $21K in Q1 2022.
- 155 funds tracked by Wall St. Rank held Horizon Bancorp as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.